NCT03278782 2026-01-09Study of Pembrolizumab (MK-3475) in Combination With RomidepsinM.D. Anderson Cancer CenterPhase 1/2 Active not recruiting39 enrolled
NCT01938833 2025-05-16Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast CancerThomas Jefferson UniversityPhase 1/2 Terminated9 enrolled 7 charts